Pharmacy Board Insists Generics Are Undersold

Law360, New York (December 18, 2006, 12:00 AM EST) -- An Oklahoma pharmacy board has asked Wal-Mart Stores Inc. and Target Corp. to review their $4 generic drug program, concerned that the retail giants’ rock-bottom prices for certain medications may violate the state’s Unfair Sales Act.

Prompted by a group of upset pharmacists, the Oklahoma State Board of Pharmacy has asked Wal-Mart and Target to make sure that they can sell the generic drugs for that price in light of the state’s competition laws.

“We are not asking them to stop the $4 program,” says Dr....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.